UAE

The facility is built to accommodate approximately 1,000 to 1,500 healthcare professionals each year, including consultants, specialists, and early-career doctors.

MIEBO contains the active ingredient perfluorohexyloctane and is the first prescription eye drop designed to target tear evaporation directly, one of the primary causes of dry eye disease.

Regulators approved the drug as an additional therapy for patients whose blood pressure remains uncontrolled despite using standard antihypertensive medicines.

To achieve the accreditation, Fakeeh University Hospital adopted the internationally recognized “Ten Steps to Successful Breastfeeding” framework developed by WHO and UNICEF.

The platform debuted across the UAE, France, Germany, Portugal, and the UK, with additional international rollouts planned in the coming months.

Through this collaboration, ZEISS supports the development of innovative imaging applications, provides scientific training opportunities, enables expert demonstrations, and facilitates knowledge exchange among research communities worldwide.

The facility will include inpatient and outpatient psychiatric services, neuro-rehabilitation units, addiction recovery programs, and specialized treatment areas for mood disorders, anxiety disorders, and child and adolescent psychiatry.

The initiative builds on PureLab’s expansive diagnostic footprint, which includes more than 145 laboratories, over 1,400 licensed clinical professionals, and more than 50 accreditations across its testing network.

The shortlisted finalists represent a diverse mix of healthcare professionals who have demonstrated leadership, innovation, and commitment to patient care in different parts of the world.

Built on the Mayo Clinic Platform, the system operates within a secure environment where Mayo Clinic teams can access large volumes of de-identified patient data.